These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 34252952)

  • 1. Modeling drug combination effects via latent tensor reconstruction.
    Wang T; Szedmak S; Wang H; Aittokallio T; Pahikkala T; Cichonska A; Rousu J
    Bioinformatics; 2021 Jul; 37(Suppl_1):i93-i101. PubMed ID: 34252952
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Learning with multiple pairwise kernels for drug bioactivity prediction.
    Cichonska A; Pahikkala T; Szedmak S; Julkunen H; Airola A; Heinonen M; Aittokallio T; Rousu J
    Bioinformatics; 2018 Jul; 34(13):i509-i518. PubMed ID: 29949975
    [TBL] [Abstract][Full Text] [Related]  

  • 3. DTF: Deep Tensor Factorization for predicting anticancer drug synergy.
    Sun Z; Huang S; Jiang P; Hu P
    Bioinformatics; 2020 Aug; 36(16):4483-4489. PubMed ID: 32369563
    [TBL] [Abstract][Full Text] [Related]  

  • 4. TranSynergy: Mechanism-driven interpretable deep neural network for the synergistic prediction and pathway deconvolution of drug combinations.
    Liu Q; Xie L
    PLoS Comput Biol; 2021 Feb; 17(2):e1008653. PubMed ID: 33577560
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Driver network as a biomarker: systematic integration and network modeling of multi-omics data to derive driver signaling pathways for drug combination prediction.
    Huang L; Brunell D; Stephan C; Mancuso J; Yu X; He B; Thompson TC; Zinner R; Kim J; Davies P; Wong STC
    Bioinformatics; 2019 Oct; 35(19):3709-3717. PubMed ID: 30768150
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Systematic identification of feature combinations for predicting drug response with Bayesian multi-view multi-task linear regression.
    Ammad-Ud-Din M; Khan SA; Wennerberg K; Aittokallio T
    Bioinformatics; 2017 Jul; 33(14):i359-i368. PubMed ID: 28881998
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ensemble Prediction of Synergistic Drug Combinations Incorporating Biological, Chemical, Pharmacological, and Network Knowledge.
    Ding P; Yin R; Luo J; Kwoh CK
    IEEE J Biomed Health Inform; 2019 May; 23(3):1336-1345. PubMed ID: 29994408
    [TBL] [Abstract][Full Text] [Related]  

  • 8. DeepSynergy: predicting anti-cancer drug synergy with Deep Learning.
    Preuer K; Lewis RPI; Hochreiter S; Bender A; Bulusu KC; Klambauer G
    Bioinformatics; 2018 May; 34(9):1538-1546. PubMed ID: 29253077
    [TBL] [Abstract][Full Text] [Related]  

  • 9. MARSY: a multitask deep-learning framework for prediction of drug combination synergy scores.
    El Khili MR; Memon SA; Emad A
    Bioinformatics; 2023 Apr; 39(4):. PubMed ID: 37021933
    [TBL] [Abstract][Full Text] [Related]  

  • 10. TAIJI: approaching experimental replicates-level accuracy for drug synergy prediction.
    Li H; Hu S; Neamati N; Guan Y
    Bioinformatics; 2019 Jul; 35(13):2338-2339. PubMed ID: 30462169
    [TBL] [Abstract][Full Text] [Related]  

  • 11. MOLI: multi-omics late integration with deep neural networks for drug response prediction.
    Sharifi-Noghabi H; Zolotareva O; Collins CC; Ester M
    Bioinformatics; 2019 Jul; 35(14):i501-i509. PubMed ID: 31510700
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A novel approach for drug response prediction in cancer cell lines via network representation learning.
    Yang J; Li A; Li Y; Guo X; Wang M
    Bioinformatics; 2019 May; 35(9):1527-1535. PubMed ID: 30304378
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Multi-way relation-enhanced hypergraph representation learning for anti-cancer drug synergy prediction.
    Liu X; Song C; Liu S; Li M; Zhou X; Zhang W
    Bioinformatics; 2022 Oct; 38(20):4782-4789. PubMed ID: 36000898
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Drug response prediction by inferring pathway-response associations with kernelized Bayesian matrix factorization.
    Ammad-Ud-Din M; Khan SA; Malani D; Murumägi A; Kallioniemi O; Aittokallio T; Kaski S
    Bioinformatics; 2016 Sep; 32(17):i455-i463. PubMed ID: 27587662
    [TBL] [Abstract][Full Text] [Related]  

  • 15. TPpred-ATMV: therapeutic peptide prediction by adaptive multi-view tensor learning model.
    Yan K; Lv H; Guo Y; Chen Y; Wu H; Liu B
    Bioinformatics; 2022 May; 38(10):2712-2718. PubMed ID: 35561206
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Network-principled deep generative models for designing drug combinations as graph sets.
    Karimi M; Hasanzadeh A; Shen Y
    Bioinformatics; 2020 Jul; 36(Suppl_1):i445-i454. PubMed ID: 32657357
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Machine learning approaches for drug combination therapies.
    Güvenç Paltun B; Kaski S; Mamitsuka H
    Brief Bioinform; 2021 Nov; 22(6):. PubMed ID: 34368832
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inferring Synergistic Drug Combinations Based on Symmetric Meta-Path in a Novel Heterogeneous Network.
    Ding P; Liang C; Ouyang W; Li G; Xiao Q; Luo J
    IEEE/ACM Trans Comput Biol Bioinform; 2021; 18(4):1562-1571. PubMed ID: 31714232
    [TBL] [Abstract][Full Text] [Related]  

  • 19. MERIDA: a novel Boolean logic-based integer linear program for personalized cancer therapy.
    Lenhof K; Gerstner N; Kehl T; Eckhart L; Schneider L; Lenhof HP
    Bioinformatics; 2021 Nov; 37(21):3881-3888. PubMed ID: 34352075
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A decision-theoretic approach to the evaluation of machine learning algorithms in computational drug discovery.
    Watson OP; Cortes-Ciriano I; Taylor AR; Watson JA
    Bioinformatics; 2019 Nov; 35(22):4656-4663. PubMed ID: 31070704
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.